Showing results (351-360 of 407) with videos related to
Sort By:
Pageof 41
Thrombosis and Haemostasis|August 21, 2024
A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, A Monoclonal Anti-HPA-1a Antibody for FNAIT PreventionChristof Geisen, Erika Fleck, Stephan Martin Gastón Schäfer, et al.Annals of the Rheumatic Diseases|September 15, 2022
2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid workAnnelies Boonen, Casper Webers, Maarten Butink, et al.Science Immunology|June 16, 2021
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patientsHector Rincon-Arevalo, Mira Choi, Ana-Luisa Stefanski, et al.Lancet (London, England)|May 11, 2020
Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trialIain B McInnes, Frank Behrens, Philip J Mease, et al.Arthritis and Rheumatism|September 2, 2008
Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countriesTuulikki Sokka, Merete Lund Hetland, Heidi Mäkinen, et al.Annals of the Rheumatic Diseases|December 17, 2016
2016 update of the EULAR recommendations for the management of early arthritisBernard Combe, Robert Landewe, Claire I Daien, et al.RMD Open|August 25, 2025
Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studiesLaura C Coates, Ricardo Blanco, Frank Behrens, et al.Therapeutic Advances in Musculoskeletal Disease|April 3, 2026
Definition of the terms used to describe psoriatic disease datasets: a HIPPOCRATES initiativeOliver FitzGerald, Catherine Smith, Christine Huppertz, et al.Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept studyChristof Geisen, Mette Kjaer, Erika Fleck, et al.Annals of the Rheumatic Diseases|February 6, 2021
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19Alessia Alunno, Aurélie Najm, Pedro M Machado, et al.Pageof 41